Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
60%
Anticarcinogen
22%
Antiemetic Agent
81%
Aprepitant
25%
Cannabis
14%
Casopitant
11%
Chemoradiation Therapy
45%
Chemotherapy
26%
Chemotherapy Induced Nausea and Vomiting
58%
Chemotherapy-Induced Peripheral Neuropathy
11%
Cisplatin
21%
Clinical Trial
11%
Cohort Study
11%
Combination Therapy
15%
Comorbidity
11%
Cross Sectional Study
16%
Cross-Sectional Study
11%
Dexamethasone
11%
Disease
14%
Emetic Agent
38%
Fluorodeoxyglucose F 18
33%
Fosaprepitant
23%
Immune Checkpoint Inhibitor
32%
Immunotherapy
30%
Ipilimumab
27%
Malignant Neoplasm
50%
Melanoma
100%
Metastatic Melanoma
44%
Nausea
44%
Nausea and Vomiting
77%
Neurokinin 1 Receptor Antagonist
31%
Nivolumab
33%
Non Small Cell Lung Cancer
22%
Overall Survival
15%
Oxaliplatin
11%
Paclitaxel
11%
Palonosetron
28%
Peripheral Neuropathy
11%
Placebo
11%
Prednisolone
11%
Prevalence
16%
Progression Free Survival
15%
Recurrent Disease
9%
Serotonin 3 Antagonist
10%
Serotonin Antagonist
12%
Side Effect
15%
Symptom
41%
Tolerability
12%
Uterine Cervix Cancer
11%
Vomiting
27%
Medicine and Dentistry
Adverse Event
16%
Anticarcinogen
18%
Antiemetic
30%
Cancer Therapy
6%
Cancer Treatment
9%
Cannabis
12%
Cannabis Use
12%
Capecitabine
5%
Carboplatin
5%
Chemoradiotherapy
12%
Chemotherapy-Induced Peripheral Neuropathy
11%
Cohort Analysis
11%
Colitis
6%
Combination Therapy
12%
Cross Sectional Study
23%
Disease
11%
Emetic Agent
41%
Fluorodeoxyglucose F 18
33%
Immune Checkpoint Inhibitor
29%
Immune-Related Adverse Events
33%
Immunotherapy
11%
Malignant Neoplasm
17%
Mental Health
11%
Metastatic Melanoma
26%
Nausea
6%
Nausea and Vomiting
44%
Nodular Melanoma
77%
Non Small Cell Lung Cancer
22%
Observational Study
5%
Oncology
8%
Overall Survival
8%
Oxaliplatin
11%
Paclitaxel
11%
Patient Experience
11%
Patient-Reported Outcome
11%
Perceptive Threshold
5%
Peripheral Neuropathy
11%
Pneumonia
6%
Positron Emission Tomography-Computed Tomography
33%
Prevalence
18%
Quality of Life
24%
Radiation Therapy
26%
Side Effect
18%
Supportive Care
11%
Symptom
24%
Thyroid Gland
11%
Thyroiditis
8%
Vibration Sense
5%
Vomiting
15%
Nursing and Health Professions
Adverse Event
14%
Anticarcinogen
7%
Antiemetic Agent
16%
Cannabis
14%
Capecitabine
5%
Carboplatin
5%
Chemoradiotherapy
11%
Chemotherapy-Induced Peripheral Neuropathy
11%
Cisplatin
13%
Correlation Coefficient
5%
Cross-Sectional Study
11%
Fluorodeoxyglucose F 18
11%
Imaging
11%
Malignant Neoplasm
9%
Melanoma
11%
Nausea
14%
Nausea and Vomiting
23%
Non Small Cell Lung Cancer
11%
Oxaliplatin
11%
Paclitaxel
11%
Palonosetron
11%
Patient-Reported Outcome
11%
Perceptive Threshold
5%
Peripheral Neuropathy
11%
Positron Emission Tomography-Computed Tomography
11%
Practice Guideline
14%
Prednisolone
11%
Prevalence
12%
Quality of Life
16%
Radiotherapy
33%
Side Effect
13%
Symptom
32%
Vomiting
11%
